Neuren Pharmaceuticals LimitedASX: NEU

Neuren commences Phase 2 trial of NNZ-2591 in Angelman

Jul 12, 2022 at 3:56 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment